Strata Skin Sciences, Inc.

SSKN Healthcare Medical Devices

Strata Skin Sciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $30.7 million, down 8.54% from fiscal 2024. In the quarter to December 2025, revenue fell 2.97%, EPS grew 111.5%, free cash flow fell 376.9% and total debt rose 1.03%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

0.00 0.00 NaN
Market cap
$1.0M
P/E
0.0×
Fwd P/E
−0.1×
Dividend yield
—
F-score
5/9
Altman Z
−11.48
Beneish M
−3.33
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Piotroski F-Score
7 5 5 5 3 6 3 2 4 5
P/S ratio
0.02 0.01 0.17 0.21 0.22 0.17 0.08 0.54 0.33 0.19
Altman Z-Score
(6.25) (6.62) (5.26) (5.52) (6.05) (6.00) (5.60) (7.68) (9.53) (11.48)
P/FCF ratio
1.60 0.09 1.77 3.16 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z″-Score (non-manufacturers)
(15.21) (16.17) (10.90) (12.74) (13.70) (13.88) (13.81) (18.87) (24.17) (30.49)
Beneish M-Score
(3.02) (5.51) (3.09) (2.95) (3.48) (2.69) (2.45) (3.91) (3.93) (3.33)
P/Operating CF
0.34 0.18 4.63 5.98 14.57 7.48 15.51 13.24 15.76 (24.52)
P/B ratio
0.03 0.02 0.16 0.23 0.19 0.20 0.13 1.43 2.23 2.02
EV/Sales
0.65 0.21 (0.13) (0.01) (0.46) 0.00 0.11 0.76 0.54 0.87
EV/EBITDA
3.68 1.15 0.00 0.00 63.89 0.00 3.19 0.00 0.00 0.00
EV/FCF
67.26 1.71 (1.39) (0.15) 60.94 (0.03) (0.82) (4.60) (12.49) (6.27)
Current Ratio
1.75 1.03 2.69 1.35 1.32 1.56 1.12 1.28 1.24 0.58
Net Debt/EBITDA
3.60 1.09 (4.13) (3.51) 94.45 17.74 0.87 (2.70) (1.74) (97.86)
Debt/Equity
1.60 0.52 0.24 0.30 0.10 0.30 0.36 1.19 3.06 5.28
ROE
(21.65%) (124.38%) (15.78%) (12.65%) (16.11%) (10.55%) (23.49%) (62.75%) (114.22%) (158.91%)
ROA
(7.15%) (52.27%) (9.31%) (7.99%) (9.34%) (5.80%) (11.23%) (22.97%) (26.22%) (19.13%)
ROIC
(6.56%) (4.32%) (9.46%) (8.67%) (24.71%) (13.44%) (12.71%) (27.42%) (50.00%) (28.40%)
Return on Tangible Assets
(22.54%) (269.53%) (20.27%) (32.99%) (38.14%) (19.26%) (47.94%) (71.50%) (76.06%) 287.60%
Average Days of Receivables
40.30 36.09 41.48 50.68 46.54 41.80 45.13 48.58 57.13 49.00
Earnings Yield
(688.89%) (5,690.48%) (79.19%) (61.50%) (86.67%) (51.20%) (193.21%) (59.62%) (92.44%) (111.90%)
Free Cash Flow Yield
62.50% 1,117.08% 56.61% 31.68% (3.43%) (42.85%) (167.81%) (30.50%) (13.07%) (72.73%)
Free Cash Flow per Share
1.52 14.08 1.47 0.66 (0.02) (0.63) (1.34) (1.59) (0.38) (0.92)
Book value per Share
69.46 73.25 15.95 8.96 7.70 7.46 6.29 3.63 1.31 0.63
Free Cash Flow
0.32 3.82 2.88 2.11 (0.06) (2.14) (4.66) (5.54) (1.45) (4.26)
EV/EBIT
0.00 0.00 1.19 0.10 2.59 0.00 0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates